top of page
Attendees

Attendees

Previous GDDIF Attendees Include:

AB Science

Almirall, S.A

Amgen

Angelini

Arvinas

Astex Pharmaceuticals

AstraZeneca

Bayer

Bicycle Therapeutics

Boehringer Ingelheim

Bristol Myers Squibb

Byondis

Carbon Logic Biotech

Centogene

Centre for Drug Design and Discovery (CD3)

Charles River Laboratories

Charm Therapeutics

Confo Therapeutics

Crescendo Biologics

Eisai

EMBL-EBI

Evox Therapeutics

Fierce Unicorn

Fisher Friedman IP Group

Freie Universitat Berlin

Galapagos NV

Genmab

Genome Biologics

Gilead Sciences

GlaxoSmithKline

Goethe-Universitat Hospital

Heath Innovation Research Alliance Northern Ireland

Hubrecht Organoid Technology

IRCCS San Raffaele

Janssen (Johnson & Johnson)

Laudea Research GmbH

Leibniz Institute for Farm Animal Biology

Leibniz Institute for Molecular Pharmacology (FMP)

Leiden University

LEO Pharma

Lhasa Limited

Lonza

Lygature

Max Delbruck Center

Max Planck Institute

Medibiofarma S.L.

Merck Group

Merck Sharp & Dohme (MSD)

Neurocrine Biosciences

Novartis

Parkinson's UK

Pfizer

Pharmablock

Radboud University Nijmegen

Roche

Sosei Heptares

Storm Therapeutics

Symeres

Technische Universitat Berlin

Tehran Polytechnic

TroplQ Health Sciences

Univercity Medicine Berlin

University of Groningen

University of Jerusalem

Vertex Pharmaceuticals

Medicinal Chemistry

CRO

CDMO

Research and Development,

Quantum Computing

New Drug Modalities

Collaborations / Business Development

Therapeutic Discovery

Advanced Therapies

Antibody Discovery

Biomarker Discovery

Screening ML / AI / LLM / Quantum / Digital

Biologics

R&D

Solution Architecture

Patient Engagement

Clinical Operations / Trials

Outsourcing

Digital Convergence

LLM, ELM, ML, AI

Data Management

Clinical Data

Computational Chemistry

Information Technology

Drug Design Cheminformatics

Bioinformatics

Automation

CEO

CTO

CSO

CMO

Director

Vice President

Divisional Heads

Managers

Executives

ETC

bottom of page